IDiyas

For the Inventor, By the Inventor

Yokohama, Japan

Yujiro Yamada

USPTO Granted Patents = 14

Average Co-Inventor Count = 6.6

ph-index = 4

Forward Citations = 37(Granted Patents)


Location History:

  • Yokohama, JA (1976 - 1978)
  • Yokahama, JP (1980)
  • Yokohama, JP (1979 - 1982)
  • Kanagawa, JP (1984)

Company Filing History:

goldMedal14 out of 382 
 
Meiji Seika Kaisha, Ltd.
 patents

Years Active: 1976-1984

Loading Chart...
14 patents (USPTO):Explore Patents
1. 4460693 - Plasmids derived from Actinomycetes (1984-07-17),
2. 4357331 - 7.alpha.Methoxycephalosporin derivatives (1982-11-02),
3. 4351830 - Polymeric compound, MF-300, with protective activity against bacterial (1982-09-28),
4. 4298599 - Novel antibiotic BN-235 substance, and process for the production thereof (1981-11-03),
5. 4283389 - Novel antibiotic, BN-183B substance (1981-08-11),
6. 4235883 - Novel antibiotic BN-213 substance and its production (1980-11-25),
7. 4226941 - Process for the optical resolution of (1980-10-07),
8. 4220639 - Antibiotics SF-2050 and SF-2050B substances and production and use (1980-09-02),
9. 4169889 - Antibiotic BN-200 substance and process for production thereof (1979-10-02),
10. 4141790 - Process for the preparation of 7-amino-cephem compounds using mold fungi (1979-02-27),
11. 4076588 - Antibiotic SF-1623 substance and the production thereof (1978-02-28),
12. 4027014 - Antibiotic BN-130 substances and the production thereof (1977-05-31),
13. 4010155 - Antibiotic SF-1623 substance (1977-03-01),
14. 3940479 - Novel antibiotic BN-109 substance, its production and use (1976-02-24),

Title: Yujiro Yamada: Innovator in Biopharmaceuticals

Introduction

Yujiro Yamada is a prominent inventor based in Yokohama, Japan. He has made significant contributions to the field of biopharmaceuticals, holding a total of 14 patents. His work focuses on innovative solutions that enhance the efficacy of pharmaceutical compounds.

Latest Patents

Among his latest patents are "Plasmids derived from Actinomycetes," which describes essentially pure plasmids that possess at least one restriction cleavage site for specific restriction enzymes and have a molecular weight of less than 1.0 × 10^7. Another notable patent is for "7.alpha.Methoxycephalosporin derivatives," which details a derivative represented by a specific formula, including various chemical groups and their configurations, aimed at improving pharmaceutical applications.

Career Highlights

Yujiro Yamada is currently employed at Meiji Seika Kaisha, Ltd., where he continues to innovate in the biopharmaceutical sector. His extensive research and development efforts have positioned him as a key figure in his field.

Collaborations

He has collaborated with notable coworkers, including Takashi Shomura and Taro Niida, contributing to various projects that advance their shared goals in biopharmaceutical research.

Conclusion

Yujiro Yamada's work exemplifies the spirit of innovation in the biopharmaceutical industry. His patents and collaborations reflect a commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…